参考文献 查看全部 ↓

• Allain JP，Candotti D.，“Diagnostic Algorithm for HBV Safe Transfusion，” Blood Transfusion 7（2009）.
• Guidance for Industry：Nucleic Acid Testing（NAT）for Human Immunodeficiency Virus Type 1（HIV-1）and Hepatitis C Virus（HCV）：Testing，Product Disposition，and Donor Deferral and Reentry，（FDA）2010.
• Kleinman SH.，Lelie N.，Busch MP.，“Infectivity of Human Immunodeficiency Virus-1，Hepatitis C Virus，and Hepatitis B Virus and Risk of Transmission by Transfusion，” Transfusion 49（2009）.
• Liu Y.，Li P.，Li C.，et al.，“Detection of Hepatitis B Virus DNA Among Accepted Blood Donors in Nanjing，” China. Virol 19（2010）.
• PAlbertoni G.，Castelo Girão MJ.，Schor N.，“Mini Review：Current Molecular Methods for the Detection and Quantification of Hepatitis B Virus，Hepatitis C Virus，and Human Immunodeficiency Virus Type 1，” Int J Infect Dis 25（2014）.
• Phikulsod S.，Oota S.，Tirawatnapong T.，et al.，“One-year Experience of Nucleic Acid Technology Testing For Human Immunodeficiency Virus Type 1，Hepatitis C Virus，and Hepatitis B Virus in Thai Blood Donations，” Transfusion 49（2009）.
• Pisani G.，Marino F.，Cristiano K.，et al.，“External Quality Assessment for the Detection of HCV RNA，HIV RNA and HBV DNA in Plasma by Nucleic Acid Amplification Technology：A Novel Approach’” Vox Sang 95（2008）.
• Ren FR，Wang JX，Huang Y.，et al.，“Hepatitis B Virus Nucleic Acid Testing in Chinese Blood Donors With Normal and Elevated Alanine Aminotransferase，” Transfusion 51（2011）.
• Roth WK.，Busch MP，Schuller A.，et al.，“International Survey on NAT Testing of Blood Donations：Expanding Implementation and Yield from 1999 to 2009，” Vox Sang 102（2012）.
• Shang G.，Seed CR.，Wang F.，et al.，“Residual Risk of Transfusion-transmitted Viral Infections in Shenzhen，China 2001 through 2004，” Transfusion 47（2007）.
• Stramer SL.，Krysztof DE.，Brodsky JP.，et al.，“Sensitivity Comparison of Two Food and Drugadministration-licensed，Triplex Nucleic Acid Test Automatedassays for Hepatitis B Virus DNA Detection and Associated Projections of United States Yield，” Transfusion 51（2011）.
• Stramer SL.，Krysztof DE.，Brodsky J.，et al.，“Comparative Analysis of Triplex NAT Assaysin US Blood donors，” Transfusion 53（2013）.
• Stramer SL.，Zou S.，Notari EP.，et al.，“Blood Donation Screening for Hepatitis B Virus Markers in The Era of Nucleic Acid Testing：Are All Tests of Value？” Transfusion 52（2012）.
• Su TH.，Chen PJ.，Chen TC.，et al.，“The Clinical Significance of Occult Hepatitis B Transfusion in Taiwan-A Look-back Study，” Transfus Med 21（2011）.
• Tabor E.，Epstein JS.，“NAT Screening of Blood and Plasma Donations Evolution of Technology and Regulatory Policy，” Transfusion 42（2002）.
• Vermeulen M.，Lelie N.，Sykes W.，et al.，“Impact of Individual-donation Nucleic Acid Testing on Risk of Human Immunodeficiency Virus，Hepatitis B Virus，and Hepatitis C Virus Transmission by Blood Transfusion in South Africa，” Transfusion 49（2009）.
• Wang L.，Chang L.，Xie Y.，et al.，“What is the Meaning of A Nonresolved Viral Nucleic Acid Test-reactive Minipool？” Transfusion 55（2015）.
• Yuen MF.，Lee CK.，Wong DK.，et al.，“Prevalence of Occult Hepatitis B Infection in A Highly Endemic Area for Chronic Hepatitis B：A Study of A Large Blood Donor Population，” Gut 59（2010）.
• 黄成垠、蒋昵真、陈显等：《血液HIV、HBV 和HCV 筛查策略的探讨》，《中国输血杂志》2015年第7期。
• 欧山海、林永财、倪宏英等：《闽南地区无偿献血者隐匿性乙型肝炎病毒感染研究》，《中国输血杂志》2010年第12期。
• 任芙蓉：《核酸检测技术在国内外血液筛检中的应用》，《北京医学》2008年第8期。
• 王迅、郑岚、张晰等：《核酸扩增技术在上海血液筛检中的初步应用》，《中国输血杂志》2003年第3期。
• 伍晓菲、谢云峥、周国平等：《上海地区献血人群隐匿性HBV感染状况》，《临床输血与检验》2011年第4期。
• 张丽、邓雪莲：《隐匿性乙肝病毒感染与血液安全》，《中国输血杂志》2011年第12期。